DHFR and cancer: Methotrexate, an antifolate drug, is one of the exceptionally successful anti-cancer medications that represses dihydrofolate reductase (DHFR) and obstructs the transformation of dihydrofolic acid (DHFA) into tetrahydrofolic acid (THFA).96